Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morten Grunnet

Showing results (131-140 of 132) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 132 results.
British Journal of Clinical Pharmacology|November 22, 2023
A phase 1 trial of AP30663, a K<sub>Ca</sub>2 channel inhibitor in development for conversion of atrial fibrillationChristina Yfanti, Birgitte Vestbjerg, Juliette Van't Westende, et al.
American Journal of Human Genetics|June 22, 2010
Identification of a Kir3.4 mutation in congenital long QT syndromeYanzong Yang, Yiqing Yang, Bo Liang, et al.
Pageof 14

Showing results (131-140 of 132) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 132 results.
British Journal of Clinical Pharmacology|November 22, 2023
A phase 1 trial of AP30663, a K<sub>Ca</sub>2 channel inhibitor in development for conversion of atrial fibrillationChristina Yfanti, Birgitte Vestbjerg, Juliette Van't Westende, et al.
American Journal of Human Genetics|June 22, 2010
Identification of a Kir3.4 mutation in congenital long QT syndromeYanzong Yang, Yiqing Yang, Bo Liang, et al.
Pageof 14